Terms: = Thyroid cancer AND TRRAP, TR-AP, 8295, ENSG00000196367, Q9Y4A5, PAF400, PAF350/400, FLJ10671, STAF40, Tra1
416 results:
1. [cancer incidence and mortality in China, 2022].
Zheng RS; Chen R; Han BF; Wang SM; Li L; Sun KX; Zeng HM; Wei WW; He J
Zhonghua Zhong Liu Za Zhi; 2024 Mar; 46(3):221-231. PubMed ID: 38468501
[No Abstract] [Full Text] [Related]
2. Occupational daily walking steps have inverse relationship with papillary thyroid cancer risk and progression: a retrospective analysis.
Zhang C; Zhang L; Su Y; Xiang L; Zhang Q; Zhang C; Huan Q
Int J Occup Med Environ Health; 2024 Mar; 37(1):58-71. PubMed ID: 38406822
[TBL] [Abstract] [Full Text] [Related]
3. Second radioiodine treatment in patients with differentiated thyroid carcinoma: Causes and effects.
Sicilia Pozo MLN; Pena Pardo FJ; Amo Salas M; Cruz Montijano M; Torres Hernández J; Padilla Bermejo A; Montalbán Méndez C; Zhao Montero M; Soriano Castrejón Á; García Vicente AM
Endocrinol Diabetes Nutr (Engl Ed); 2024 Jan; 71(1):4-11. PubMed ID: 38388076
[TBL] [Abstract] [Full Text] [Related]
4. Efficacy and safety of pralsetinib in Chinese advanced RET-mutant medullary thyroid cancer patients.
Zheng X; Fang M; Fan Y; Sun Y; Sun M; Yang A; Zhang B; Liu Q; Liu H; Zhou X; Huang T; Qin J; Wang Z; Qin M; Shen Z; Yao S; Yang J; Wang Y; Gao M
Endocr Relat Cancer; 2024 Apr; 31(4):. PubMed ID: 38261313
[TBL] [Abstract] [Full Text] [Related]
5. The Diagnostic Value of
Cui B; Wu Z; Yu B; Li Y; Liu H
Discov Med; 2023 Dec; 35(179):1064-1070. PubMed ID: 38058071
[TBL] [Abstract] [Full Text] [Related]
6. Real-time reliable semantic segmentation of thyroid nodules in ultrasound images.
Xing G; Wang S; Gao J; Li X
Phys Med Biol; 2024 Jan; 69(2):. PubMed ID: 38048630
[No Abstract] [Full Text] [Related]
7. Risk factors for central lymph node metastasis in patients with papillary thyroid carcinoma: a retrospective study.
Du J; Yang Q; Sun Y; Shi P; Xu H; Chen X; Dong T; Shi W; Wang Y; Song Z; Shang X; Tian X
Front Endocrinol (Lausanne); 2023; 14():1288527. PubMed ID: 38047112
[TBL] [Abstract] [Full Text] [Related]
8. Pralsetinib in Patients with Advanced/Metastatic Rearranged During Transfection (RET)-Altered thyroid cancer: Updated Efficacy and Safety Data from the ARROW Study.
Subbiah V; Hu MI; Mansfield AS; Taylor MH; Schuler M; Zhu VW; Hadoux J; Curigliano G; Wirth L; Gainor JF; Alonso G; Adkins D; Godbert Y; Ahn MJ; Cassier PA; Cho BC; Lin CC; Zalutskaya A; Barata T; Trask P; Scalori A; Bordogna W; Heinzmann S; Brose MS
Thyroid; 2024 Jan; 34(1):26-40. PubMed ID: 38009200
[No Abstract] [Full Text] [Related]
9. Prediagnostic serum concentrations of per- and polyfluoroalkyl substances and risk of papillary thyroid cancer in the Finnish Maternity Cohort.
Madrigal JM; Troisi R; Surcel HM; Öhman H; Kivelä J; Kiviranta H; Rantakokko P; Koponen J; Medgyesi DN; Kitahara CM; McGlynn KA; Sampson J; Albert PS; Ward MH; Jones RR
Int J Cancer; 2024 Mar; 154(6):979-991. PubMed ID: 37902275
[TBL] [Abstract] [Full Text] [Related]
10. Age-stratified comparison of active surveillance versus radiofrequency ablation for papillary thyroid microcarcinoma using decision analysis.
Carlisle KM; Brown JP; Kim J; Turner DJ; Slejko JF; Kuo JH; Mullins CD; Hu Y
Surgery; 2024 Jan; 175(1):153-160. PubMed ID: 37872047
[TBL] [Abstract] [Full Text] [Related]
11. Effects of Ultrasound-Guided Laser Ablation Therapy on Symptomatic Benign thyroid Nodules, Using EchoLaser - Results of a Pilot Study in the United States.
Thomas J; Ledger GA; Haertling T
Endocr Pract; 2023 Dec; 29(12):942-947. PubMed ID: 37704167
[TBL] [Abstract] [Full Text] [Related]
12. Systematic vitamin D supplementation is associated with improved outcomes and reduced thyroid adverse events in patients with cancer treated with immune checkpoint inhibitors: results from the prospective PROVIDENCE study.
Bersanelli M; Cortellini A; Leonetti A; Parisi A; Tiseo M; Bordi P; Michiara M; Bui S; Cosenza A; Ferri L; Giudice GC; Testi I; Rapacchi E; Camisa R; Vincenzi B; Caruso G; Rauti AN; Arturi F; Tucci M; Santo V; Ricozzi V; Burtet V; Sgargi P; Todeschini R; Zustovich F; Stucci LS; Santini D; Buti S
Cancer Immunol Immunother; 2023 Nov; 72(11):3707-3716. PubMed ID: 37638980
[TBL] [Abstract] [Full Text] [Related]
13. Contraception and sterilization selection at delivery among pregnant patients with malignancy.
Harris CA; Mandelbaum RS; Rau AR; Song BB; Klar M; Ouzounian JG; Paulson RJ; Roman LD; Matsuo K
Acta Obstet Gynecol Scand; 2024 Apr; 103(4):695-706. PubMed ID: 37578024
[TBL] [Abstract] [Full Text] [Related]
14. Polygenic Risk and Chemotherapy-Related Subsequent Malignancies in Childhood cancer Survivors: A Childhood cancer Survivor Study and St Jude Lifetime Cohort Study Report.
Im C; Sharafeldin N; Yuan Y; Wang Z; Sapkota Y; Lu Z; Spector LG; Howell RM; Arnold MA; Hudson MM; Ness KK; Robison LL; Bhatia S; Armstrong GT; Neglia JP; Yasui Y; Turcotte LM
J Clin Oncol; 2023 Sep; 41(27):4381-4393. PubMed ID: 37459583
[TBL] [Abstract] [Full Text] [Related]
15. Risk factors and survival prediction of young breast cancer patients with liver metastases: a population-based study.
Pu CC; Yin L; Yan JM
Front Endocrinol (Lausanne); 2023; 14():1158759. PubMed ID: 37424855
[TBL] [Abstract] [Full Text] [Related]
16. thyroid surgery outcomes in octogenarians: A national analysis.
Sakowitz S; Bakhtiyar SS; Khoraminejad B; Ebrahimian S; Madrigal J; Benharash P; Wu J
Surgery; 2023 Jul; 174(1):52-58. PubMed ID: 37055292
[TBL] [Abstract] [Full Text] [Related]
17. Whole-exome sequencing and bioinformatic analyses revealed differences in gene mutation profiles in papillary thyroid cancer patients with and without benign thyroid goitre background.
Eng ZH; Abdullah MI; Ng KL; Abdul Aziz A; Arba'ie NH; Mat Rashid N; Mat Junit S
Front Endocrinol (Lausanne); 2022; 13():1039494. PubMed ID: 36686473
[TBL] [Abstract] [Full Text] [Related]
18. Radiotherapy and paclitaxel plus pazopanib or placebo in anaplastic thyroid cancer (NRG/RTOG 0912): a randomised, double-blind, placebo-controlled, multicentre, phase 2 trial.
Sherman EJ; Harris J; Bible KC; Xia P; Ghossein RA; Chung CH; Riaz N; Gunn GB; Foote RL; Yom SS; Wong SJ; Koyfman SA; Dzeda MF; Clump DA; Khan SA; Shah MH; Redmond K; Torres-Saavedra PA; Le QT; Lee NY
Lancet Oncol; 2023 Feb; 24(2):175-186. PubMed ID: 36681089
[TBL] [Abstract] [Full Text] [Related]
19. Alcoholic liver disease in relation to cancer incidence and mortality: Findings from a large, matched cohort study in South Korea.
Tran TPT; Han M; Luu NM; Oh JK
Cancer Med; 2023 Apr; 12(7):8754-8766. PubMed ID: 36653955
[TBL] [Abstract] [Full Text] [Related]
20. Models of ultrasonic radiomics and clinical characters for lymph node metastasis assessment in thyroid cancer: a retrospective study.
Zhu H; Yu B; Li Y; Zhang Y; Jin J; Ai Y; Jin X; Yang Y
PeerJ; 2023; 11():e14546. PubMed ID: 36650830
[TBL] [Abstract] [Full Text] [Related]
[Next]
